Abstract
Background: The Amblyopia Treatment Studies (ATS) are randomized, multicenter clinical trials. ATS 1 compared patching to atropine for moderate amblyopia. Two-year follow-up is now complete, and we will follow these children to 15 years of age. ATS 2 compared patching regimens for moderate and severe amblyopia. In addition, ATS 2 monitored patients for evidence of recurrence after cessation of therapy. ATS 3 evaluated treatment of older children 7 to 17 years of age. ATS4 compared weekend to daily atropine.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
